1.
Correlation Between Serum HBV DNA and HBeAg Levels in Patients with Chronic Hepatitis B
慢性乙肝患者血清HBV-DNA和HBeAg定量的相关性分析
2.
The Characteristic of TCM Type of Syndromes and the Relationship between Them and the Ration of HBV-DNA in Patients with HBeAg-negative Chronic Hepatitis B Patients;
HBeAg阴性慢性乙肝证型分布及与HBVDNA定量的关系
3.
Roadmap for Patients Receiving Oral Therapy for Chronic Hepatitis B and Quantification of HBV DNA、HBeAg and HBsAg level
慢性乙肝治疗路线图和HBV DNA、HBeAg、HBsAg定量的监测意义
4.
The Predictive Value of Dynamitic HBeAg Quantitation and HBV-DNA to Virology Response in Treating Chronic Hepatitis B Using Peginterferon Alfa-2a
HBeAg和HBVDNA动态定量在聚乙二醇干扰素治疗慢性乙型肝炎中的预测价值
5.
(2) BCP mutation may impair HBeAg expression.
BCP双突变对HBeAg的表达有一定影响 ;
6.
The stability of the La protein binding site-deleted HBeAg mRNA in cells
La蛋白结合位点缺失的HBeAg mRNA在细胞内的稳定性
7.
The Correlation with T-lymphocyte Subsets、HBeAg Level、ALT/AST and the Diseases with HBV Infection;
T细胞亚群、HBeAg含量、ALT/AST与HBV感染相关疾病的关系
8.
Clinical and Laboratory Study on the Chronic Hepatitis B Patients of HBeAg-positive and Lamivudine-resistant with Adefovir Dipivoxil Treatment
阿德福韦酯治疗拉米夫定耐药HBeAg阳性的慢性乙肝的临床研究
9.
Clinical Observation on Lam ivudine combined Thymosin α_1 in Treating HBeAg-negative Chronic Hepatitis B
拉米夫定联合胸腺肽α_1治疗HBeAg阴性慢性乙型肝炎临床观察
10.
The clinical effect of telbivudine combined with oxymatrine for Patients with HBeAg positive chronic hepatitis B
替比夫定联合苦参素治疗HBeAg阳性慢性乙型肝炎的疗效观察
11.
Therapeutic effect of 48 weeks of telbivudine on HBeAg-positive chronic hepatitis B
替比夫定治疗HBeAg阳性慢性乙型肝炎48周疗效观察
12.
Influence of Chinese Patent Medicines Combined with Lamivudine on Sero-HBeAg in Chronic Hepatitis B Patients
拉米夫定联合中成药对慢性乙型肝炎血清HBeAg的影响
13.
Efficacy of Lamivudine Therapy for HBeAg-positive Chronic Hepatitis B in Interferon Nonresponders
拉米夫定治疗干扰素无应答HBeAg阳性慢性乙肝患者的疗效
14.
Clinical Observation on the Effect of Telbivudine Combined with Kushenin on the Treatment on HBeAg Positive Chronic Hepatitis B Patients
替比夫定联合苦参素治疗HBeAg阳性慢性乙型肝炎临床观察
15.
Analysis on efficacy and safety of Adefovirdipivoxil therapy for patients with HBeAg(+) chronic hepatitis B resistant to Lamivudine
阿德福韦酯治疗拉米夫定耐药性HBeAg阳性慢性乙型肝炎的疗效及安全性分析
16.
The comparison of clinical features between the patients with HBeAg-positive and HBeAg-negative hepatitis B liver cirrhosis
HBeAg阳性和HBeAg阴性乙肝后肝硬化临床特征比较
17.
Exploration of the Cause for Negative Result Detected of HBVDNA-positive Patientes HBeAg;
HBVDNA阳性患者HBeAg阴性的原因探讨
18.
The Study of Using RNAi to Inhibit the Expression of HBeAg in Vitro;
RNA干扰体外抑制HBeAg表达的实验研究